content

Anixa Biosciences collaborates with Urology Centers of Alabama on Cchek early prostate cancer detection study

Anixa Biosciences, Inc., a biotechnology company, announced a collaboration with Urology Centers of Alabama (UCA) in the Cchek early prostate cancer detection study. UCA...

Biogen completes enrollment in phase 3 STAR study of gene therapy timrepigene emparvovec to treat inherited retinal disorder

Biogen Inc, a global biotechnology company, announced the enrollment of the last patient in the global phase 3 STAR clinical study, which is evaluating...

Aptar Pharmas Preservative-Free Multidose Dispenser Approved in the US for Allergans REFRESH RELIEVA PF Artificial Tear Formulation

Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the delivery system...

DuPont Reveals Enhanced Application and Innovation Center, Increased Production Capacity at CPhI India

DuPont Nutrition & Biosciences has consistently advanced its customers forward by ensuring global access to indispensable ingredients and unmatched expertise. At CPhI India, Nov....

Heraeus expands cancer therapy API capacity

Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients (Pt HPAPIs) with...

India to grow strongly in 2020 as CPhI & P-MEC India opens

CPhI & P-MEC India โ€“ organised by Informa Markets โ€“ is set to open its doors to more than 43,000 attendees from 120 countries...

DuPont Reveals Enhanced Application and Innovation Center, Increased Production Capacity at CPhI India

DuPont Nutrition & Biosciences has consistently advanced its customers forward by ensuring global access to indispensable ingredients and unmatched expertise. At CPhI India, the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read